Suspended lead suits significantly reduced interventional echocardiographers' radiation exposure to the head compared to conventional aprons during left atrial appendage occlusion procedures. The ...
According to the Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation, patients with heart failure are classified into: heart failure with reduced ejection fraction (HFrEF, LVEF ...
Anticoagulation is a critical component in the treatment of cardiovascular diseases. Large randomised controlled trials have ...
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, ...
Cardiology is emerging as the medical device segment to watch in 2026, with several recent earnings calls highlighting its momentum across the industry. The cardiac space saw rapid transformation in ...
Mason, Ohio-based AtriCure, a specialist in surgical treatments and therapies for atrial fibrillation, left atrial appendage management, and post-operative pain management, saw substantial revenue ...
A first look at the implant success and sealing efficacy of a dual-seal left atrial appendage occlusion (LAAO) device that’s in development reveals successful implantation in 99.8% of people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results